Figure S4
Screen for proteins localizing to NPGs eYFP-fusions of proteins involved in various aspects of RNA metabolism were co-expressed with an NPG marker protein, either mChFP-DHH1, SCD6-mChFP or PABP2-mChFP. All transgenes, except LSM5-eYFP, were expressed after modification of one endogenous allele. LSM5-eYFP was expressed as a tetracycline-inducible transgene using a pDEX377 derivative (Kelly et al., 2007) EALRLFKSGACQVLVATDVASRGLDIPNVGVVIQYDMPSNIDDYVHRIGRTGRAGKVGVA 512 :*** **.*: :**:**.******** *: **:*****:*************.*: * *
VASA TSFFDPEKDRAIAADLVKILEGSGQTVPDFLRTCG------------AGGDGGYS-----632 Tb927.10.14550
ISFFN-EKNRNIVDDLIPLLNETNQVISPEVRALAKRPNNNNNNNNRGGGGGGYRGFGRG 571 ***: **:* *. **: :*: :.*.:. :*: . .**.*** 
VASA ----------------------------NQNFGGVDVRGRGNYVG---------------649

Figure S9
The decrease in P-bodies seen after SCD6 RNAi is unlikely to be caused by the RNAi process itself, as RNAi knock-down of two proteins, FLAI or Polo-like kinase, does not cause a decrease in P-bodies. eYFP-DHH1 localization to P-bodies was monitored following RNAi depletion of either (A) FLAI or (B) Polo-like kinase. FLAI depletion resulted in detached flagella as previously reported (La Count et al., 2002) . Depletion of Polo-like-kinase caused an increase in 1K2N cells and at later time-points in multinuclear cells with usually a smaller number of kinetoplasts than nuclei due to a defect in kinetoplast division (Hammarton et al., 2007) . Neither RNAi resulted in a decrease in P-bodies, but rather an increase. Table S1 : Details of all plasmids used in this work. All backbone plasmids are described in Kelly et al., 2007 or Sunter et al., 2012 , although in some cases a different selectable marker was used, as indicated.
